Atracurium Besylate is a Intravenous Injection, Solution in the Human Prescription Drug category. It is labeled and distributed by Auromedics Pharma Llc. The primary component is Atracurium Besylate.
Product ID | 55150-216_1b797826-b3a4-4546-be5e-55424c8bba2b |
NDC | 55150-216 |
Product Type | Human Prescription Drug |
Proprietary Name | Atracurium Besylate |
Generic Name | Atracurium Besylate |
Dosage Form | Injection, Solution |
Route of Administration | INTRAVENOUS |
Marketing Start Date | 2015-04-08 |
Marketing Category | ANDA / ANDA |
Application Number | ANDA206010 |
Labeler Name | AuroMedics Pharma LLC |
Substance Name | ATRACURIUM BESYLATE |
Active Ingredient Strength | 50 mg/5mL |
Pharm Classes | Neuromuscular Nondepolarizing Blockade [PE],Nondepolarizing Neuromuscular Blocker [EPC] |
NDC Exclude Flag | N |
Listing Certified Through | 2019-12-31 |
Marketing Start Date | 2015-04-08 |
NDC Exclude Flag | N |
Sample Package? | N |
Marketing Category | ANDA |
Application Number | ANDA206010 |
Product Type | HUMAN PRESCRIPTION DRUG |
Billing Unit | ML |
Marketing Start Date | 2015-04-08 |
Ingredient | Strength |
---|---|
ATRACURIUM BESYLATE | 50 mg/5mL |
SPL SET ID: | 71d4bc78-57df-474b-8b19-811a959f1fce |
Manufacturer | |
UNII | |
RxNorm Concept Unique ID - RxCUI | |
UPC Code |
NDC | Brand Name | Generic Name |
---|---|---|
0409-1105 | Atracurium Besylate | ATRACURIUM BESYLATE |
0409-1109 | Atracurium Besylate | ATRACURIUM BESYLATE |
25021-659 | Atracurium Besylate | atracurium besylate |
25021-672 | Atracurium Besylate | atracurium besylate |
55150-216 | Atracurium Besylate | Atracurium Besylate |
55150-217 | Atracurium Besylate | Atracurium Besylate |
65862-984 | Atracurium Besylate | Atracurium Besylate |
65862-985 | Atracurium Besylate | Atracurium Besylate |
67457-698 | Atracurium Besylate | atracurium besylate |
67457-699 | Atracurium Besylate | atracurium besylate |
71288-701 | Atracurium Besylate | Atracurium Besylate |
71288-702 | Atracurium Besylate | Atracurium Besylate |